A Charleston-area roofing company is officially being ejected from its workspace amid complaints that it took hundreds of ...

A new inhalable gene therapy for cystic fibrosis (CF) has entered Phase I clinical trials, a major milestone on the journey ...

Did you see this? Nearly 1 in 10 Americans have asthma. Here's what causes it.

An inhalable medicine with the potential to improve lung disease in people with cystic fibrosis, irrespective of their ...

An inhaled gene therapy for cystic fibrosis developed by Boehringer Ingelheim is due to start clinical testing shortly, hoping to become a first-in-class treatment for the genetic disorder.

Boehringer Ingelheim, IP Group, the UK Respiratory Gene Therapy Consortium (GTC) 1 and OXB, 1 today announce the start of LENTICLAIR TM 1, a Phase I/II trial of BI 3720931, a novel, first-in-class, ...

The global Cystic Fibrosis Market is valued at $10.4 billion in 2023 and is projected to reach $55.4 billion by 2032, ...

Once-daily vanzacaftor-tezacaftor-deutivacaftor was safe and well-tolerated in children with cystic fibrosis, while ...

Vertex Pharmaceuticals forecast annual revenue largely above Wall Street estimates on Monday, banking on robust sales of its ...

An inhalable medicine with the potential to improve lung disease in people with cystic fibrosis is being tested in human ...

The Charleston Mom Prom is a charity event hosted by the Cystic Fibrosis Foundation, bringing women together to help make a ...